1. Introduction
Human milk is the gold standard for the neonatal feeding, growth, and health of infants worldwide [
1,
2]. Infant formulas are a safe nutritional alternative to support growth and normal development in infants, whenever human milk feeding is not possible [
3]. Most infant formulas are produced with bovine milk as the main source of protein and carbohydrates. However, different approaches to the infant formula composition have been evaluated to address gastrointestinal lactose intolerance and food allergies to the standard cow-protein-based formulas. Such approaches include the hydrolyzed-protein formulas, lactose-free or lactose reduced formulas, and soy-protein-based formulas [
4,
5]. In the USA, approximately 12% of the infant formula market are soy-based formulas [
6]. Different studies have reported that soy-based formulas support the normal growth and development of full-term infants [
7,
8,
9,
10]. Recently, a randomized clinical trial reported that soy-based formulas can reduce gastrointestinal symptoms in infants with cow’s milk intolerance, including the reduction in gas, crying, and a higher formed stool in healthy infants [
11]. Although soy-protein formulas are recommended as a nutritional alternative to human milk in full-term infants [
12], some concerns on the risk of phytoestrogen concentration in soy-based formulas have been raised [
13,
14], as well as the lower bone mineralization observed in infants fed a soy-based formula during the first year of life [
15]. There is an increasing interest in plant-based alternatives due to allergies, intolerance, or for perceived health benefits or cultural values, which are leading some families to feed their babies plant-based “milks” that are not designed specifically for infant or young children and are deficient in nutrients [
16,
17]. Although certain nuts can be allergenic for some individuals and their use should be evaluated with caution for allergic individuals [
18], the common protein sources in infant formulas, cow milk and soy, are major allergens. Moreover, recent guidelines recommend the early introduction of allergens to infants below the age of 12 months [
19,
20]. However, a nutritious plant-based formula with a different source of protein rather than soy-protein is needed due to the allergies to dairy milk protein, intolerance to lactose, and to provide an option to those following veganism practices.
The evaluation of the safety of infant formulas is essential to determine the impact of different ingredients on the infants’ health, nutritional status, and to prevent long-term metabolic disorders. In the present study, we compare the growth, organ development, and metabolic parameters in the plasma of piglets fed a dairy-based formula or a plant-based formula from postnatal day (PND) 2 until PND 21 in a controlled environment. We hypothesized that the plant-based formula that contains almond butter and buckwheat flour tested in this study provides an adequate nutritional source relative to the other infant formula alternatives in the market.
2. Materials and Methods
2.1. Experimental Design and Animal Care
The Institutional Animal Care and Use Committee (IACUC) at the University of Arkansas for Medical Sciences approved all animal care and experimental procedures (UAMS Institutional Animal Care and committee protocol# 4022). Piglets were purchased from a biomedical research farm (Oak Hill Genetics, Ewing, IL, USA), which meets all the requirements of Class “A” licensee by the United States Department of Agriculture (USDA). After birth, piglets were allowed to suckle at their respective sows for 48 h prior to being transported to the animal facility of the Arkansas Children’s Hospital Research Institute. Upon arrival, at postnatal day 2 (PND 2), 18 crossbred (Yorkshire/Landrace cross with some Duroc on the boar side) intact male and female piglets were randomly assigned into 2 dietary groups of approximately equal mean weight (n = 9/diet group): dairy-based infant formula (Similac Advance powder; Abbott Nutrition Abbott Laboratories, Columbus, OH, USA) or plant-based formula (Else Nutrition GH Ltd., Tel Aviv 6971070, Israel). At PND 2, piglets were trained to drink from nipples on a fixed schedule to provide 1.047 MJ/kg/day until sacrifice on day 21. Formula-fed piglets were individually housed, which allowed the monitoring of milk intake at each feeding and the evaluation of stool consistencies. This animal trial was completed in 3 replicates (6 piglets/replicate), with 3 piglets/diet selected from 2 different sows. All piglets were housed in the animal facility from PND 2 until PND 21. Piglets were observed daily during the course of the experimental study for any signs of stress by trained and experienced technical staff or by the investigators. No medication treatment was used during the trial. Two piglets (1/diet group) had diarrhea during the postnatal days 3–8. These piglets were treated with Pedialyte as per veterinarian recommendation and IACUC requirement to help with electrolyte loss. All the piglets completed the study.
2.2. Diet Groups
The plant-based formula was formulated and supplied by the Else Nutrition GH Ltd. (main ingredients: almond butter and buckwheat flour), while the dairy-based formula (Similac Advance powder) was purchased from the commercial company (Abbott Nutrition Abbott Laboratories, Columbus, OH, USA). To meet the nutritional requirements of growing pigs by the National Research Council (NRC) [
21], both diets were supplemented with a blend of nutrients, which was formulated and produced by Envigo Teklad Diets (Madison, WI, USA). The complete list of nutrients in each formula is shown in
Table 1. The formula powder was reconstituted fresh daily with water, safflower, and coconut oils to meet the daily desired caloric intake (based on the body weight) of 300 Kcals at first week, 200 Kcals at second week, and 175 Kcals at third week divided by the number of feeds. The feeding schedule was as follows: first week was every 2 h, second week was every 4 h, and third week was every 6 h.
2.3. Sample Collection and Measurements
Body weights were measured daily throughout the trial. Firstly, 2 h after morning feeding (e.g., 6 a.m.), blood samples were collected weekly starting at day 5 until 21 days of age, with piglets under anesthesia using a tight-fitting mask with a dose of 3–5% isoflurane and with oxygen between 0.8 to 1.5 L/min. Prior to blood collection, the neck was shaved and cleaned with 70% alcohol scrubs. The weekly blood draws were performed based on the circulating blood volume (CBV) of 7.5% and the estimated CBV of 60 mL/kg. At day 21, blood collection was a terminal bleed. Blood was collected via cardiac puncture with an 18-gauge 3-inch needle and 20 mL syringes, while piglets were under anesthesia. On day 21 after exsanguination, several organs and tissues were collected for further analysis, including gastrointestinal tract tissues (duodenum, jejunum, ileum, proximal and distal colon), gastrointestinal tract contents, as well as mesenteric lymph nodes, spleen, liver, and kidney.
2.4. Metabolic and Trace Mineral Profiling in Plasma
At the weekly blood draws, approximately 2.5 mL of whole blood was collected into K2EDTA vacutainer tubes (BD Biosciences, Cat#367844), 2.0 mL into lithium heparin vacutainer tubes (BD Biosciences, Cat#367880, Franklin Lakes, NJ, USA), and 2.5 mL into blood RNA tubes (BD, PAXgene®, Cat#762165, Franklin Lakes, NJ, USA). In addition, using 2 drops of whole blood per piglet, 2 slide smears were collected. Plasma samples were obtained by spinning the lithium heparin tubes at 1500× g for 10 min at 4 °C. A total of 500 uL of plasma, K2EDTA tubes, and the blood smear samples were submitted to the Veterinary Medical Diagnostic Laboratory at Texas A&M University (College Station, TX, USA) for metabolic profiling, mineral panel, and complete blood count (CBC), respectively. Additionally, plasma samples were submitted to the Eurofins Craft Technologies Laboratory (Wilson, NC, USA) for plasma insulin measurements using a quantitative porcine insulin ELISA assay. At day 21, the blood (~45 mL) was collected into serum vacutainer tubes (BD Biosciences, Cat#368045, Franklin Lakes, NJ, USA) as well as into blood RNA tubes for further analysis. Serum tubes were incubated at room temperature for approximately 20 min and then centrifuged at 1500× g for 10 min at 4 °C. Serum aliquots were stored at −80 °C until further processing.
2.5. Statistical Analysis
This study was designed as a 2 × 2 factorial arrangement of treatments (dairy-based and plant-based). Some study responses were measured repeatedly over time, while some comparisons were performed at the endpoint time. Therefore, the proposed study design with 9 animals per group with roughly equal gender representation and equal mean body weight for the piglets at PND 2 (enrollment day) has approximately 80% power to detect 1.25 standard deviation units between the diet groups testing at the 5% level of significance. The statistical analysis was conducted in the SAS version 9.4 (Cary, NC, USA) and GraphPad Prism software version 9.1.2 (San Diego, CA, USA). Group comparisons of body weights, calories intake, and plasma parameters overtime and their interactions (Group × Time) were analyzed by repeated measures analysis of variance (ANOVA) followed by Sidak’s multiple-comparisons adjusted p-value. Group comparisons for the organ weights and length were assessed by two-tailed Mann–Whitney test (non-parametric test). Statistical significance was declared at p ˂ 0.05.
4. Discussion
Human milk is the best nutrition for infants, but many infants are fed infant formula due to maternal choice or other reasons. The increasing interest in plant-based feeding options for infants and young children led to the development of alternatives whose safety should be verified.
The present study demonstrated that the consumption of the plant-based formula was well tolerated (no fever observations, similar fecal consistencies, and no signs of prolonged diarrhea events) by piglets during the first 3 weeks of life. Furthermore, the similar observations in body weight and kcal intake throughout the experiment between the dairy-based and plant-based formula fed animals showed that the plant-based formula utilized in the current study also supported adequate growth in those piglets. The daily body weight measured in all the piglets was in line with the growth reported in sow-fed piglets during the neonatal phase [
22,
23,
24] or soy-fed piglets reported by others [
25], and in line with our previous findings, in which piglets received pasteurized human milk, dairy-based milk formula or sow-fed piglets [
26]. Additionally, the gastrointestinal tract development as well as that of the organs examined were similar between both dietary groups and are comparable with neonatal piglets that received a dairy-based milk formula [
27] or soy formula [
28] for 21 days. Moreover, all plasma measures during the study are within the normal range reported for this age group, including CBC [
22], chemistry [
29], minerals [
30] and all liver enzymes.
Neonates have high variability in several plasma biomarkers due to the accelerated growth and physiological adaptations during this period [
31]. Therefore, there is a different reference range for plasma metabolites of neonates, young animals, and adults. For instance, bilirubin, which is the end product of the red blood cells catabolism, has been reported to be higher than the rate in adults due to the increased red blood cell turnover in newborns [
32]. Serum alkaline phosphatase (ALP) is also 2–3 times higher in the plasma of neonates compared to healthy adult subjects [
33], and its activity is commonly used as a clinical biomarker of bone metabolism and liver function; such processes include the transport of phosphates and calcium into the intestinal tissues, and bone mineralization [
34].
The hematological variables measured in the present study are in accordance with the reference intervals for sow-fed piglets at a similar age (5 and 30 days old) and housed in a controlled environment [
22]. Our CBC analysis showed a decrease in neutrophil percentage with age, while an increase in the percentage of lymphocytes was observed from 1 to 3 weeks of age in all piglets. These findings are consistent with the CBC reported in term infants in whom the neutrophil count peaked at the first 24 h of life and then decreased by 3 days of age [
35,
36]. Taken together, our data do not suggest an adverse effect of feeding a plant-based formula to neonatal piglets on the circulating cells. As calcium absorption and bone mineralization is of high importance in young infants and clinical trials have reported a lower bone mineralization in infants fed a soy-protein-based formula at 3 months of age [
15], the difference in calcium observed in the first week may worth further examination of calcium metabolism, or bone mineralization.
Circulating proteins that are produced by the hepatocytes serve as liver function biomarkers [
37]. Our trial demonstrated that plant-based-fed piglets had statistically higher albumin, total protein, and globulins concentration at 1 week of age compared to the dairy-based group. These levels reported in the plasma of the plant-based-fed piglets are higher than the levels reported by other studies that fed swine milk formula supplemented with 3′-siallylactose sodium salt to piglets from 2 to 21 days of age [
38]. However, as the parameters are within normal range, probably there is no clinical significance to these observations.
The normal concentration of glucose in the plasma of newborn infants is 2.5 mmol/L (45 mg/dL) to 7.0 mmol/L (126 mg/dL). Though the average measured glucose levels in this study are within this range, more piglets in the dairy-based group had plasma glucose levels higher that the above as compared to the plant-based group. In addition, no difference in insulin levels were noted between the two diet groups. The differences observed may point to a more stable glucose metabolism in the plant-based group, a direction worth of further exploration.
One concern of plant-based products is around the antinutrients and especially phytate content decreasing the bioavailability of minerals and trace elements. Thus, the results reveal that the nutrient absorption was not compromised in the plant-based group, as shown by the similarity in caloric intake, growth pattern, and mineral plasma concentrations, which is of high significance to demonstrate the non-inferiority of this formula.
Pigs as an animal model for biomedical research have been extensively used, among other reasons, due to the physiological and anatomical similarities between pigs and humans [
39,
40]. Additionally, piglets during the first 3 weeks of life (i.e., neonatal phase) have been used to translate observations to human neonates due to the similar physiology and microbiota establishment and digestibility upon neonatal diet feeding between pigs and infants [
41,
42,
43]. The safety of many infant formula ingredients was demonstrated in this model. Thus, this study used a neonatal piglet model to examine the safety and efficacy of a plant-based formula with almonds and buckwheat as the main ingredients, but the neonatal porcine model used in this study has some limitations. Piglets were enrolled in the trial at 2 days of age by which time the colostrum quality and amount consumed are unknown and they were from different sows. We acknowledge that such limitations might have introduced some baseline variation that might affect the findings. Additionally, to meet the energy and nutrient requirements for growing pigs, both diets were calculated to meet equal levels of additional protein and other compounds. This neonatal piglet experiment is a standard model to test neonatal diet and this porcine model has been used by different researchers [
28,
43,
44,
45], including for the evaluation of soy-protein-based formulas [
46,
47]. Despite the addition of nutrients to both formula diets, the infant formulas represent a significant component of the diets, and the fact that animals from both diets were maintained in a controlled environment (housed at the vivarium on a 12 h light/dark cycle), had similar growth, and both groups had similar kcal intake per day validate our results based on the neonatal diet offered to the piglets.